Lackner, N.; Thomé, C.; Öfner, D.; Joannidis, M.; Mayerhöfer, T.; Arora, R.; Samardzic, E.; Posch, W.; Breitkopf, R.; Lass-Flörl, C.
COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility. J. Fungi 2022, 8, 93.
https://doi.org/10.3390/jof8020093
AMA Style
Lackner N, Thomé C, Öfner D, Joannidis M, Mayerhöfer T, Arora R, Samardzic E, Posch W, Breitkopf R, Lass-Flörl C.
COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility. Journal of Fungi. 2022; 8(2):93.
https://doi.org/10.3390/jof8020093
Chicago/Turabian Style
Lackner, Nina, Claudius Thomé, Dietmar Öfner, Michael Joannidis, Timo Mayerhöfer, Rohit Arora, Eldina Samardzic, Wilfried Posch, Robert Breitkopf, and Cornelia Lass-Flörl.
2022. "COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility" Journal of Fungi 8, no. 2: 93.
https://doi.org/10.3390/jof8020093
APA Style
Lackner, N., Thomé, C., Öfner, D., Joannidis, M., Mayerhöfer, T., Arora, R., Samardzic, E., Posch, W., Breitkopf, R., & Lass-Flörl, C.
(2022). COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility. Journal of Fungi, 8(2), 93.
https://doi.org/10.3390/jof8020093
